These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2138442)

  • 1. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients.
    Ralston SH; Gallacher SJ; Patel U; Campbell J; Boyle IT
    Ann Intern Med; 1990 Apr; 112(7):499-504. PubMed ID: 2138442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial.
    Thürlimann B; Waldburger R; Senn HJ; Thiébaud D
    Ann Oncol; 1992 Sep; 3(8):619-23. PubMed ID: 1450043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic hypercalcaemia in lung cancer.
    Campbell JH; Ralston S; Boyle IT; Banham SW
    Respir Med; 1991 May; 85(3):223-7. PubMed ID: 1831917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic possibilities in paraneoplastic hypercalcemia].
    Schürer CC; Peters U; Fischer JT
    Med Welt; 1981 Aug; 32(32-33):1219-21. PubMed ID: 6456397
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmon calcitonin in the acute management of hypercalcemia.
    Wisneski LA
    Calcif Tissue Int; 1990; 46 Suppl():S26-30. PubMed ID: 2137363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
    Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
    Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
    Thiébaud D; Jacquet AF; Burckhardt P
    Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia and childhood cancer: a 7-year experience.
    Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
    Zojer N; Keck AV; Pecherstorfer M
    Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia in patients with oral squamous cell carcinoma.
    Iwase M; Kurachi Y; Kakuta S; Sakamaki H; Nakamura-Mitsuhashi M; Nagumo M
    Clin Oral Investig; 2001 Sep; 5(3):194-8. PubMed ID: 11642565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia.
    Zhang SJ; Hu Y; Cao J; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6715-9. PubMed ID: 24377594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
    Ling PJ; A'Hern RP; Hardy JR
    Br J Cancer; 1995 Jul; 72(1):206-9. PubMed ID: 7599053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality and Outcomes of Treatment of Hypercalcemia of Malignancy.
    Wright JD; Tergas AI; Ananth CV; Burke WM; Hou JY; Chen L; Neugut AI; Richards CA; Hershman DL
    Cancer Invest; 2015; 33(8):331-9. PubMed ID: 26068056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional treatment of hypercalcemia of malignancy.
    Davidson TG
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S8-15. PubMed ID: 11757206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M; Takemi T; Manabe M; Nagumo M
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute management of cancer-related hypercalcemia.
    Chisholm MA; Mulloy AL; Taylor AT
    Ann Pharmacother; 1996 May; 30(5):507-13. PubMed ID: 8740333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.